help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STOLTZ, D. A.
Right arrow Articles by BAGBY, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STOLTZ, D. A.
Right arrow Articles by BAGBY, G. J.

Am. J. Respir. Crit. Care Med., Volume 161, Number 1, January 2000, 135-140

In Vitro Ethanol Suppresses Alveolar Macrophage TNF-alpha during Simian Immunodeficiency Virus Infection

DAVID A. STOLTZ, STEVE NELSON, JAY K. KOLLS, PING ZHANG, RUDOLF P. BOHM Jr., MICHAEL MURPHEY-CORB, and GREGORY J. BAGBY

Department of Medicine, Section of Pulmonary/Critical Care, Department of Physiology, Alcohol Research Center, and Department of Pediatrics, Louisiana State University Medical Center, New Orleans, Louisiana; Tulane Regional Primate Research Center, Covington, Louisiana; and School of Medicine and Primate Center for Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania

Pulmonary infections are a significant cause of morbidity and mortality in patients with alcohol abuse and human immunodeficiency virus (HIV) infection, two immunocompromising conditions that frequently coexist. This study examined the separate and combined effects of in vivo lentiviral infection and in vitro alcohol exposure on alveolar macrophage (AM) production of tumor necrosis factor- alpha (TNF-alpha ), a proinflammatory cytokine that is critical to normal pulmonary host defense. AMs, recovered by bronchoalveolar lavage (BAL) from uninfected and simian immunodeficiency virus (SIV)-infected rhesus macaques, at the asymptomatic and terminal stages of infection, were cultured in ethanol 2 h prior to stimulation with lipopolysaccharide (LPS). Median TNF-alpha concentrations were measured 15 h later. Spontaneous TNF-alpha production was similar in all groups examined. LPS increased TNF-alpha protein production similarly in SIV(-) (2,381 ± 359 pg/ml) and SIV(+) animals at the terminal stage of infection (2,019 ± 507 pg/ml). In contrast, cells from SIV(+) asymptomatic animals had a depressed response (763 ± 304 pg/ml). Ethanol (100 mM) suppressed the LPS-induced AM TNF-alpha response by approximately 50% in both SIV(-) and (+) animals. Ethanol-induced suppression of the TNF-alpha response occurred at a post-transcriptional level. These data suggest that ethanol-induced suppression of the pulmonary TNF-alpha response may further increase the susceptibility to and severity of secondary infectious complications in HIV-infected hosts. Stoltz DA, Nelson S, Kolls JK, Zhang P, Bohm RP, Jr., Murphey-Corb M, Bagby GJ. In vitro ethanol suppresses alveolar macrophage TNF-alpha during simian immunodeficiency virus infection.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
D. M. Boe, R. W. Vandivier, E. L. Burnham, and M. Moss
Alcohol abuse and pulmonary disease
J. Leukoc. Biol., November 1, 2009; 86(5): 1097 - 1104.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. L. Lucas, R. A. Brown, M. Wassef, and T. D. Giles
Alcohol and the Cardiovascular System: Research Challenges and Opportunities
J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1916 - 1924.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
H. Friedman, C. Newton, and T. W. Klein
Microbial Infections, Immunomodulation, and Drugs of Abuse
Clin. Microbiol. Rev., April 1, 2003; 16(2): 209 - 219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society
  New Orleans Int'l Conf